The NSW Government is investing in pioneering research into the medicinal cannabis industry, with Minister for Agriculture, Adam Marshall unveiling a new $10 million study from a top-secret cannabis research facility in regional NSW, last week.
The research study is the result of a collaboration between the NSW Government, Cann Group Limited, Southern Cross University, Aglive Pty Ltd and the University of Newcastle's NHMRC Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE).
The Commonwealth Government will co-invest $3 million into the project through its Cooperative Research Centre Program, which supports industry-led collaborations between industry, researchers and the community.
This ground-breaking research study will consider all aspects of the supply chain, including everything from ideal growing conditions to medicinal compound analysis.
ACRE Director and the University of Newcastle clinical pharmacologist Professor Jennifer Martin said this new study was another critical step in providing high quality medicinal cannabis products to patients.
"Our national research centre based at the University of Newcastle is focused on ensuring quality and safety in the implementation of medicinal cannabis use in the community. We are excited to contribute our research expertise in clinical pharmacology to this new study," Professor Martin said.
The industry-led study was initiated by Cann Group Limited, the first company to be issued a Medicinal Cannabis License and Cannabis Research License by the Australian Government.
The NSW Government will contribute more than $3 million to the project and the other partners almost $4 million.
